LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment.

    Senarathne, Udara Dilrukshi / Jasinge, Eresha / Viknarajah Mohan, Sarojini / Waidyanatha, Samantha

    BMJ case reports

    2022  Volume 15, Issue 3

    Abstract: Pompe disease is an autosomal-recessive inherited disorder of glycogen metabolism due to lysosomal acid alpha-glucosidase deficiency. The infantile-onset form is rapidly fatal if left untreated and presents with respiratory symptoms, a typical encounter ... ...

    Abstract Pompe disease is an autosomal-recessive inherited disorder of glycogen metabolism due to lysosomal acid alpha-glucosidase deficiency. The infantile-onset form is rapidly fatal if left untreated and presents with respiratory symptoms, a typical encounter during infancy. We discuss two infants presenting with respiratory symptoms since early infancy and found to have cardiomegaly, hypotonia, elevated muscle enzymes, leading to the diagnosis of Pompe disease with genetic confirmation. However, both infants expired before the enzyme replacement therapy due to complications of irreversible muscle damage despite supportive medical care. Presentation with respiratory symptoms common during childhood, absence of alarming symptoms such as hypoglycaemia, ketoacidosis or encephalopathy, and relative rarity of Pompe disease can contribute to lapses in the early diagnosis as observed in the index patients. Thus, these cases emphasise the importance of vigilant assessment of common paediatric presentations, which may be presenting symptoms of underlying sinister pathologies.
    MeSH term(s) Cardiomegaly ; Child ; Enzyme Replacement Therapy ; Glycogen Storage Disease Type II/complications ; Glycogen Storage Disease Type II/diagnosis ; Glycogen Storage Disease Type II/drug therapy ; Humans ; Infant ; Muscle Hypotonia/complications ; alpha-Glucosidases/genetics ; alpha-Glucosidases/therapeutic use
    Chemical Substances alpha-Glucosidases (EC 3.2.1.20)
    Language English
    Publishing date 2022-03-09
    Publishing country England
    Document type Case Reports ; Journal Article
    ISSN 1757-790X
    ISSN (online) 1757-790X
    DOI 10.1136/bcr-2021-247312
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.

    Dissanayake, Ruwangi / Samarasinghe, Nayana / Waidyanatha, Samantha / Pathirana, Sajeewani / Neththikumara, Nilaksha / Dissanayake, Vajira H W / Wetthasinghe, Kalum / Gooneratne, Lallindra / Wickramasinghe, Pujitha

    BMC pediatrics

    2022  Volume 22, Issue 1, Page(s) 344

    Abstract: Background: Iron overload (IO) is a complication in transfusion dependent beta thalassaemia (TDT). Pathogenic variants in genes involving iron metabolism may confer increased risk of IO. The objective of this study was to determine the magnitude of the ... ...

    Abstract Background: Iron overload (IO) is a complication in transfusion dependent beta thalassaemia (TDT). Pathogenic variants in genes involving iron metabolism may confer increased risk of IO. The objective of this study was to determine the magnitude of the cardiac and hepatic IO and determine whether pathogenic variants in HFE, SLC40A1 and TFR2 genes increase the risk of IO in a cohort of TDT patients in Sri Lanka.
    Materials and methods: Fifty-seven (57) patients with TDT were recruited for this study. Serum ferritin was done once in 3 months for a period of one year in all. Those who were ≥ 8 years of age (40 patients) underwent T2* MRI of the liver and heart. Fifty-two (52) patients underwent next generation sequencing (NGS) to identify pathogenic variants in HBB, HFE, SLC40A1 and TFR2 genes.
    Results: The median age of the patients of this cohort was 10 years. It comprised of 30 (52.6%) boys and 27 (47.4%) girls. The median level of serum ferritin was 2452 ng/dl. Hepatic IO was seen in 37 (92.5%) patients and cardiac IO was seen in 17 (42.5%) patients. There was no statistically significant correlation between serum ferritin and hepatic or cardiac IO. Thirty-two (61.5%), 18 (34.6%), 2 (3.8%) of patients were homozygotes, compound heterozygotes and heterozygotes for pathogenic variants in the HBB gene. Eight (15.4%) and 1 (1.9%) patients were heterozygotes for pathogenic and likely pathogenic variants of HFE genes respectively. There were no pathogenic variants for the TfR2 and SLC40A1 genes. The heterozygotes of the pathogenic variants of the HFE were not at increased risk of IO.
    Conclusions: Cardiac T2* MRI helps to detect cardiac IO in asymptomatic patients. It is important to perform hepatic and cardiac T2* MRI to detect IO in patients with TDT. There was no statistically significant correlation between pathogenic variants of HBB and HFE genes with hepatic and cardiac IO in this cohort of patients.
    MeSH term(s) Cation Transport Proteins/genetics ; Child ; Female ; Ferritins ; Hemochromatosis Protein/genetics ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Humans ; Iron Overload/complications ; Iron Overload/genetics ; Male ; Mutation ; Receptors, Transferrin/genetics ; Sri Lanka ; beta-Globins/genetics ; beta-Thalassemia/complications ; beta-Thalassemia/genetics ; beta-Thalassemia/therapy
    Chemical Substances Cation Transport Proteins ; HFE protein, human ; Hemochromatosis Protein ; Histocompatibility Antigens Class I ; Receptors, Transferrin ; TFR2 protein, human ; beta-Globins ; metal transporting protein 1 ; Ferritins (9007-73-2)
    Language English
    Publishing date 2022-06-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041342-7
    ISSN 1471-2431 ; 1471-2431
    ISSN (online) 1471-2431
    ISSN 1471-2431
    DOI 10.1186/s12887-022-03191-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.

    Vidanapathirana, Dinesha Maduri / Rodrigo, Thushara / Waidyanatha, Samantha / Jasinge, Eresha / Hooper, Amanda J / Burnett, John R

    Global pediatric health

    2017  Volume 4, Page(s) 2333794X17715839

    Language English
    Publishing date 2017-06-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2785531-4
    ISSN 2333-794X ; 2333-794X
    ISSN (online) 2333-794X
    ISSN 2333-794X
    DOI 10.1177/2333794X17715839
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top